Stem Cell Transplant and Bone Marrow Transplant Procedures for
As part of the Mario Lemieux Center for Blood Cancers, the Stem Cell Transplantation Program of UPMC CancerCenter is committed to developing and improving stem cell transplantation (SCT) therapies for adults and children with blood and bone cancers, as well as other diseases.
As one of the largest regional providers of stem cell transplantation services in western Pennsylvania, this accredited program offers tailored treatment on an outpatient or inpatient basis.
Program leaders work closely with experts in the Leukemia and Lymphoma Program of UPMC CancerCenter and perform approximately 130 transplants annually.
The Stem Cell Translation Program at UPMC CancerCenter offers a complete and comprehensive array of SCT services, including:
- Allogeneic transplant — Physicians collect and transplant stem cells from a donor who matches the recipients' cells.
- Autologous transplant — Stem cells are harvested from the person prior to other cancer treatments, purged of abnormal cells, and transplanted into the patient.
- Syngeneic transplant — Similar to an allogeneic transplant; however, the donor cells are collected from the person's identical twin
UPMC CancerCenter's program participates in the International Bone Marrow Registry and the Autologous Blood and Marrow Transplant Registry, providing patients with the greatest opportunity to find a donor match if needed.
The program is an approved transplant center by the National Cancer Institute's Eastern Cooperative Oncology Group (ECOG), a national multi-institutional organization that coordinates and facilitates cancer-related clinical trials.
Through ECOG, the program can offers participation in innovative clinical trials of promising new transplant approaches to treat the disease. Search the database for currently accruing trials, or contact the program at 412-235-1052.
Learn more about stem cell transplantation at the Mario Lemieux Center for Blood Cancers.